Kiyomi Mashima

544 total citations
29 papers, 206 citations indexed

About

Kiyomi Mashima is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Kiyomi Mashima has authored 29 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Genetics and 8 papers in Immunology. Recurrent topics in Kiyomi Mashima's work include Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Kiyomi Mashima is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Kiyomi Mashima collaborates with scholars based in Japan, United States and Russia. Kiyomi Mashima's co-authors include Kaoru Hatano, Yoshinobu Kanda, Yasufumi Kawasaki, Masahiro Ashizawa, Shin‐ichiro Fujiwara, Kazuya Sato, Ryoko Yamasaki, Iekuni Oh, Ken Ohmine and Kento Umino and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Kiyomi Mashima

25 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyomi Mashima Japan 10 84 46 45 45 44 29 206
Mojdeh Naghashpour United States 10 112 1.3× 61 1.3× 63 1.4× 28 0.6× 43 1.0× 14 275
Krisztián Kállay Hungary 9 44 0.5× 25 0.5× 53 1.2× 65 1.4× 28 0.6× 27 196
Hajime Senjo Japan 9 79 0.9× 49 1.1× 36 0.8× 54 1.2× 30 0.7× 31 222
Chad P. Soupir United States 8 182 2.2× 52 1.1× 25 0.6× 42 0.9× 92 2.1× 9 304
Giorgia Saporiti Italy 8 55 0.7× 59 1.3× 51 1.1× 26 0.6× 18 0.4× 18 177
Juan José Rodríguez‐Sevilla Spain 10 62 0.7× 40 0.9× 33 0.7× 51 1.1× 40 0.9× 34 211
Luděk Pour Czechia 8 61 0.7× 16 0.3× 51 1.1× 69 1.5× 25 0.6× 88 206
Rocco Pastano Italy 10 177 2.1× 64 1.4× 33 0.7× 66 1.5× 74 1.7× 19 285
Christos Smias Greece 10 169 2.0× 122 2.7× 71 1.6× 83 1.8× 40 0.9× 14 313
Piotr Boguradzki Poland 7 35 0.4× 63 1.4× 34 0.8× 33 0.7× 66 1.5× 28 232

Countries citing papers authored by Kiyomi Mashima

Since Specialization
Citations

This map shows the geographic impact of Kiyomi Mashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyomi Mashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyomi Mashima more than expected).

Fields of papers citing papers by Kiyomi Mashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyomi Mashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyomi Mashima. The network helps show where Kiyomi Mashima may publish in the future.

Co-authorship network of co-authors of Kiyomi Mashima

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyomi Mashima. A scholar is included among the top collaborators of Kiyomi Mashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyomi Mashima. Kiyomi Mashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mashima, Kiyomi, Yanan Kuang, Stacey M. Fernandes, et al.. (2025). Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia. Leukemia. 39(8). 2026–2029.
2.
Sato, Kazuya, Hiroko Hayakawa, Takashi Ikeda, et al.. (2024). Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease. ImmunoHorizons. 8(3). 228–241. 2 indexed citations
3.
Mashima, Kiyomi, Stacey M. Fernandes, Svitlana Tyekucheva, et al.. (2024). Complex Karyotype, but Not Isolated TP53 mutation, Predicts Overall Survival in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy. Blood. 144(Supplement 1). 583–583.
4.
Tyekucheva, Svitlana, et al.. (2023). Higher Mutational Burden Is an Independent Predictor of Shorter Time to First Treatment in Untreated Chronic Lymphocytic Leukemia Patients. Blood. 142(Supplement 1). 3270–3270. 2 indexed citations
5.
6.
Hatano, Kaoru, Shin‐ichiro Fujiwara, Kento Umino, et al.. (2022). Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma. Annals of Hematology. 101(6). 1211–1216. 3 indexed citations
7.
Inagaki, Takeshi, Ken Fujiwara, Yoshiaki Shinohara, et al.. (2021). Perivascular macrophages produce type I collagen around cerebral small vessels under prolonged hypertension in rats. Histochemistry and Cell Biology. 155(4). 503–512. 16 indexed citations
8.
Mashima, Kiyomi, Iekuni Oh, Ken Fujiwara, et al.. (2021). Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models. PLoS ONE. 16(1). e0245232–e0245232. 6 indexed citations
9.
Mashima, Kiyomi, Kazuya Sato, Takashi Ikeda, et al.. (2020). Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells. Blood. 136(Supplement 1). 24–25. 1 indexed citations
10.
Kawasaki, Yasufumi, Kazuya Sato, Kiyomi Mashima, et al.. (2020). Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction. Transplantation and Cellular Therapy. 27(3). 231.e1–231.e8. 8 indexed citations
11.
Mashima, Kiyomi, Morio Azuma, Ken Fujiwara, et al.. (2020). Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine Leukemias. ACTA HISTOCHEMICA ET CYTOCHEMICA. 53(3). 43–53. 2 indexed citations
12.
Ito, Shoko, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2019). Evaluation of thrombotic events in patients with immune thrombocytopenia. Annals of Hematology. 99(1). 49–55. 14 indexed citations
13.
Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2018). Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology. 23(8). 470–477. 20 indexed citations
14.
Kawasaki, Yasufumi, Kazuya Sato, Hiroko Hayakawa, et al.. (2018). Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(8). 1563–1574. 24 indexed citations
15.
Mashima, Kiyomi, Iekuni Oh, Takashi Ikeda, et al.. (2018). Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma & Leukemia. 18(12). e521–e527. 12 indexed citations
16.
Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations
17.
Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2017). Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. Hematology. 22(9). 521–526. 6 indexed citations
18.
Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2017). Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia. International Journal of Hematology. 106(3). 411–417. 1 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mojdeh Naghashpour Breakdown of academic impact, for papers by Krisztián Kállay Breakdown of academic impact, for papers by Hajime Senjo Breakdown of academic impact, for papers by Chad P. Soupir Breakdown of academic impact, for papers by Giorgia Saporiti Breakdown of academic impact, for papers by Juan José Rodríguez‐Sevilla Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Rocco Pastano Breakdown of academic impact, for papers by Christos Smias Breakdown of academic impact, for papers by Piotr Boguradzki
Rankless by CCL
2026